Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CDT Equity Inc. Director's Dealing 2025

Dec 22, 2025

35495_dirs_2025-12-22_96308ba8-0e8d-49ea-8d2c-f18d0b7d20d7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CDT Equity Inc. (CDT)
CIK: 0001896212
Period of Report: 2025-12-08

Reporting Person: Regan Andrew (Director, Chief Executive Officer, 10% Owner)
Reporting Person: Corvus Capital Ltd. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-08 Common Stock A 224800 $1.79 Acquired 227304 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-08 Pre-Funded Warrants $0.0001 A 3685815 Acquired Common Stock (3685815) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 140005 Direct
Common Stock 19349 Indirect
Common Stock 14 Indirect

Footnotes

F1: On December 8, 2025, CDT Equity Inc. (the "Company") and Corvus Capital Limited ("Corvus") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the "Pre-Funded Warrants"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities.

F2: Based on the closing price per share of Common Stock on December 7, 2025.

F3: These shares of Common Stock are owned of record by Corvus.

F4: These shares of Common Stock are owned of record by Manoira Corporation ("Manoira").

F5: These shares of Common Stock are owned of record by Algo Holdings, Inc. ("Algo").

F6: Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, including with respect to the Pre-Funded Warrant Shares, except to the extent of its or his pecuniary interest therein.

F7: Until exercised in full.